These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29311936)
1. Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation. Wang Y; Zhou FM Front Pharmacol; 2017; 8():935. PubMed ID: 29311936 [TBL] [Abstract][Full Text] [Related]
2. Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice. Sagot B; Li L; Zhou FM Front Neural Circuits; 2018; 12():57. PubMed ID: 30104963 [TBL] [Abstract][Full Text] [Related]
3. The antiparkinson drug ropinirole inhibits movement in a Parkinson's disease mouse model with residual dopamine neurons. Wang Y; Bouabid S; Darvas M; Zhou FM Exp Neurol; 2020 Nov; 333():113427. PubMed ID: 32735872 [TBL] [Abstract][Full Text] [Related]
4. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output. Ding S; Li L; Zhou FM J Neurophysiol; 2015 Mar; 113(6):1697-711. PubMed ID: 25552639 [TBL] [Abstract][Full Text] [Related]
5. Similar L-dopa-stimulated motor activity in mice with adult-onset 6-hydroxydopamine-induced symmetric dopamine denervation and in transcription factor Pitx3 null mice with perinatal-onset symmetric dopamine denervation. Li L; Sagot B; Zhou FM Brain Res; 2015 Jul; 1615():12-21. PubMed ID: 25960345 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum. Wei W; Ding S; Zhou FM J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785 [TBL] [Abstract][Full Text] [Related]
7. Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice. Wei W; Li L; Yu G; Ding S; Li C; Zhou FM J Neurophysiol; 2013 Nov; 110(9):2203-16. PubMed ID: 23945778 [TBL] [Abstract][Full Text] [Related]
8. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597 [TBL] [Abstract][Full Text] [Related]
9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
10. Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's Disease. Kostrzewa JP; Kostrzewa RA; Kostrzewa RM; Brus R; Nowak P Curr Top Behav Neurosci; 2016; 29():313-332. PubMed ID: 26475156 [TBL] [Abstract][Full Text] [Related]
12. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. Robertson GS; Robertson HA J Neurosci; 1989 Sep; 9(9):3326-31. PubMed ID: 2795165 [TBL] [Abstract][Full Text] [Related]
13. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Dupre KB; Eskow KL; Negron G; Bishop C Brain Res; 2007 Jul; 1158():135-43. PubMed ID: 17553470 [TBL] [Abstract][Full Text] [Related]
14. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function. Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144 [TBL] [Abstract][Full Text] [Related]
15. Extrastriatal dopaminergic circuits of the Basal Ganglia. Rommelfanger KS; Wichmann T Front Neuroanat; 2010; 4():139. PubMed ID: 21103009 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Actions between L-DOPA and Different Dopamine Agonists in Striatal DA-Depleted Microcircuits In Vitro: Pre-Clinical Insights. Lara-González E; Duhne M; Ávila-Cascajares F; Cruz S; Bargas J Neuroscience; 2019 Jul; 410():76-96. PubMed ID: 31078685 [TBL] [Abstract][Full Text] [Related]
17. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei. Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472 [TBL] [Abstract][Full Text] [Related]
18. D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum. Avila-Luna A; Prieto-Leyva J; Gálvez-Rosas A; Alfaro-Rodriguez A; Gonzalez-Pina R; Bueno-Nava A Neurochem Res; 2015 Jul; 40(7):1431-7. PubMed ID: 25981954 [TBL] [Abstract][Full Text] [Related]
20. Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines. Zhong M; Wang Y; Lin G; Liao FF; Zhou FM Neurobiol Dis; 2023 Jun; 181():106096. PubMed ID: 37001611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]